Sort
51,593 grants matching “hepatitis”
Role of the innate immune defenses in viral infections
$1,009,907Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
Hepatic Clearance Chip for Pharmacokinetics
$1,009,594Murat Cirit · Javelin Biotech · R44 · FY2023 · TR
Macaque and human models for preclinical development of iPSCs
$1,009,452Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Postmortem Pathology
$1,008,987David E Kleiner · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Cerebral Structural And Metabolic Correlates Of Aggressive Or Addictive Behavior
$1,008,738Daniel W Hommer · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2012 · AA
Mechanisms of Therapy and Model Development in Viral Hepatitis and Liver Diseases
$1,008,066T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Studies of HCV Infection And HCV-Host interactions
$1,008,066T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Clinical Validation Center for Hepatocellular Carcinoma
$1,007,940Amit Singal · Ut Southwestern Medical Center · U01 · FY2024 · CA
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
$1,007,817Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Newborn cohorts to discover and validate biomarkers of neonatal vaccine immunogenicity
$1,007,530Ofer Levy · Boston Children'S Hospital · U19 · FY2018 · AI
A Topical Non Steroidal Anti-inflammatory for Rosacea
$1,007,031Braham Shroot · Signum Biosciences · R44 · FY2011 · AI
Endothelial Dysfunction, Oxidative Stress and Risk of Peripheral Arterial Disease
$1,006,905Kenneth Jay Mukamal · Beth Israel Deaconess Medical Center · R01 · FY2009 · HL
2/6 COMpAAAS U01: Observation Study
$1,006,227Amy Caroline Justice · Yale University · U01 · FY2017 · AA
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)
$1,006,217David W Crabb · Indiana University Indianapolis · U01 · FY2014 · AA
Chimpanzee Biomedical Research Program Limited Competition (U42)
$1,006,169M. Babette Fontenot · University Of Louisiana At Lafayette · U42 · FY2013 · OD
Analysis and Modulation of Virus-Host Interaction in Infections of the Liver
$1,005,702Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK
Defining Natural History and Optimal Treatment Outcome for Chronic HBV Infection
$1,005,626Norah A. Terrault · University Of California, San Francisco · U01 · FY2012 · DK
Multidisciplinary Studies of Hematopoietic Malignancies
$1,005,265Lindsay Morton · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,005,132Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
A hepatocyte-specific R-spondin mimetic bispecific fusion protein to stimulate hepatocyte regeneration in patients with acute alcoholic hepatitis
$1,005,000Jay Tibbitts · Surrozen Operating, Inc. · U01 · FY2020 · AA
2/6 COMpAAAS U01: Observation Study
$1,004,763Amy Caroline Justice · Yale University · U01 · FY2018 · AA
Saline Enhanced Radiofrequency Ablation for Liver Tumors
$1,004,711Michael G Curley · Thermedical, Inc. · R44 · FY2006 · CA
Targeting the checkpoint regulator VISTA for treatment of inflammatory disease
$1,004,563Jay L Rothstein · Immunext, Inc. · R44 · FY2019 · AI
Childhood Liver Disease Research Network (ChiLDReN) Scientific and Data Coordinating Center
$1,004,513John C Magee · University Of Michigan At Ann Arbor · U24 · FY2025 · DK
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
$1,003,946Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA